These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2882057)

  • 1. Protection against duodenal ulceration by somatostatins.
    Palitzsch KD; Schuler H; Schwedes U; Usadel KH
    Klin Wochenschr; 1986; 64 Suppl 7():93-6. PubMed ID: 2882057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pentobarbital anesthesia and bile acids on cysteamine-induced duodenal and gastric ulcers in rats.
    Schwedes U; Clémençon GH; Paschke R; Usadel KH
    Scand J Gastroenterol Suppl; 1984; 92():121-4. PubMed ID: 6146197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric mucosal protection by somatostatins.
    Kusterer K; Rohr G; Schwedes U; Usadel KH; Szabo S
    Klin Wochenschr; 1986; 64 Suppl 7():97-9. PubMed ID: 2882058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced ghrelin secretion in rats with cysteamine-induced duodenal ulcers.
    Fukuhara S; Suzuki H; Masaoka T; Arakawa M; Hosoda H; Minegishi Y; Kangawa K; Ishii H; Kitajima M; Hibi T
    Am J Physiol Gastrointest Liver Physiol; 2005 Jul; 289(1):G138-45. PubMed ID: 15778430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical changes in tissue catecholamines and serotonin in duodenal ulceration caused by cysteamine or propionitrile in the rat.
    Szabo S; Horner HC; Maull H; Schnoor J; Chiueh CC; Palkovits M
    J Pharmacol Exp Ther; 1987 Mar; 240(3):871-8. PubMed ID: 3559978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin prevents cysteamine-induced duodenal ulcer.
    Schwedes U; Usadel K; Szabo S
    Eur J Pharmacol; 1977 Jul; 44(2):195-6. PubMed ID: 885169
    [No Abstract]   [Full Text] [Related]  

  • 7. Diversion of bile and pancreatic secretion in the rat and its effect on cysteamine-induced duodenal and peptic ulcer development under maximal acid secretion.
    Clémençon GH; Fehr HF; Finger J
    Scand J Gastroenterol Suppl; 1984; 92():112-5. PubMed ID: 6588494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoprotective properties of somatostatins.
    Usadel KH; Kessler H; Rohr G; Kusterer K; Palitzsch KD; Schwedes U
    Klin Wochenschr; 1986; 64 Suppl 7():59-63. PubMed ID: 2882051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of tyrosine administration on duodenal ulcer induced by cysteamine in the rat.
    Oishi T; Szabo S
    J Pharmacol Exp Ther; 1987 Mar; 240(3):879-82. PubMed ID: 3559979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dopamine-related drugs on duodenal ulcer induced by cysteamine or propionitrile: prevention and aggravation may not be mediated by gastrointestinal secretory changes in the rat.
    Gallagher G; Brown A; Szabo S
    J Pharmacol Exp Ther; 1987 Mar; 240(3):883-9. PubMed ID: 3559980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin depletion by cysteamine: mechanism and implication for duodenal ulceration.
    Szabo S; Reichlin S
    Fed Proc; 1985 Jun; 44(9):2540-5. PubMed ID: 2860015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterisation of the somatostatin analogue TT-232: effects on neurogenic and non-neurogenic inflammation and neuropathic hyperalgesia.
    Pintér E; Helyes Z; Németh J; Pórszász R; Pethö G; Thán M; Kéri G; Horváth A; Jakab B; Szolcsányi J
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):142-50. PubMed ID: 12122501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interrelation between the analgesic and ulcerogenic action of cysteamine].
    Vinogradov VA; Polonskiĭ VM; Siutkin EA; Smagin VG
    Biull Eksp Biol Med; 1984 Nov; 98(11):582-3. PubMed ID: 6509176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteamine-induced duodenal ulcer is not site-specific: effect of local modulating factors.
    Adler RS; Nafradi J; Szabo S
    J Exp Pathol; 1985; 2(2):111-22. PubMed ID: 3842391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of cysteamine on the Brunner gland secretion in the rat.
    Kirkegaard P; Poulsen SS; Halse C; Loud FB; Skov Olsen P; Christiansen J
    Scand J Gastroenterol; 1981; 16(1):93-6. PubMed ID: 7233083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of bile salts in cysteamine-induced duodenal ulcer in the rat and the ulceroprotective property of lysolecithin.
    Clémençon GH; Fehr HF; Finger J
    Scand J Gastroenterol Suppl; 1984; 92():116-20. PubMed ID: 6588495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of nitrofurans on duodenal ulceration induced by cysteamine or indometacin.
    Ali BH
    Pharmacology; 1991; 42(1):49-53. PubMed ID: 2057520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candida albicans aggravates duodenal ulcer perforation induced by administration of cysteamine in rats.
    Nakamura T; Yoshida M; Ishikawa H; Kameyama K; Wakabayashi G; Otani Y; Shimazu M; Tanabe M; Kawachi S; Kumai K; Kubota T; Saikawa Y; Sano K; Kitajima M
    J Gastroenterol Hepatol; 2007 May; 22(5):749-56. PubMed ID: 17444866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor inhibits cysteamine-induced duodenal ulcers.
    Kirkegaard P; Olsen PS; Poulsen SS; Nexø E
    Gastroenterology; 1983 Dec; 85(6):1277-83. PubMed ID: 6605273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of local secretory and motility changes in the pathogenesis of experimental duodenal ulcer.
    Szabo S; Pihan G; Gallagher GT; Brown A
    Scand J Gastroenterol Suppl; 1984; 92():106-11. PubMed ID: 6588493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.